FDA Inspection 1110013 — Atlas Analytical Inc.

Atlas Analytical Inc. — FEI 3014434540

The FDA completed an inspection of Atlas Analytical Inc. on Nov 14, 2019 in Brooksville, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 14, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Brooksville, FL (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
180921 CFR 211.160(a)Following/documenting laboratory controls
189021 CFR 211.165(e)Test methods
197521 CFR 211.182Written records kept in individual logs
261921 CFR 211.198(b)(2)Complaint Investigation/Follow-Up Findings

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.